Cargando…
Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors
BACKGROUND: As the most convenient and commonly used for clinical diagnosis, cancer biomarker has been widely used in the auxiliary diagnosis of tumors, the observation of curative effect, the judgment of prognosis, and the monitoring of the disease. METHODS: Pan-cancer analysis was used to validate...
Autores principales: | An, Zhongwu, Bo, Weibo, Qin, Jibao, Jiang, Ling, Jiang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362825/ https://www.ncbi.nlm.nih.gov/pubmed/37484140 http://dx.doi.org/10.18502/ijph.v52i6.12957 |
Ejemplares similares
-
Prognostic Value of Serum Interleukin-6, NF-κB plus MCP-1 Assay in Patients with Diabetic Nephropathy
por: An, Zhongwu, et al.
Publicado: (2022) -
Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer
por: Li, Huang-bao, et al.
Publicado: (2020) -
A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer
por: Seibert, Julia K, et al.
Publicado: (2015) -
CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis
por: Dai, Xiyu, et al.
Publicado: (2023) -
DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)